Sign In
Buy AKTS
$28.70
+1.69 (+6.26%)
At Close: Jun 24, 2026
Huge Insider Buying Now at This Insurance Giant and 2 Biotechs
08:45am, Monday, 19'th Jan 2026
In the past week, a beneficial owner has continued to build a stake in insurance giant W.R.
Market Today: Chips, energy and housing lead -- TSM, MU, NVO in focus
05:35pm, Friday, 16'th Jan 2026
Guru Stock PicksRichard Pzena has made the following transactions:Add in MBUU by 2.48%Stock News Stocks end flat as chips rally: Taiwan Semiconductor (TSM) and
Market Today: TSMC beat, Goldman soars, Spotify hikes
05:35pm, Thursday, 15'th Jan 2026
Stock News Verizon issues credits after outage: Verizon (VZ) said it resolved a nationwide wireless outage and will offer a $20 account credit to affected custo
Market Today: Verizon outage, Tesla FSD shift, banks in focus
05:35pm, Wednesday, 14'th Jan 2026
Guru Stock PicksAndreas Halvorsen has made the following transactions:Add in RRX by 5.71%Stock News Verizon service outage hits users: Verizon (VZ) reported a w
A Fresh IPO That Long-Term Investors Shouldn't Ignore
09:32am, Wednesday, 14'th Jan 2026
For speculative investors, the start of each year is always a good time to revisit an initial public offering (IPO) calendar. Almost every week, companies go public, with a handful of them offering co
First Look: Alphabet $4T, Nvidia China OK, Boeing Tops Airbus
07:39am, Wednesday, 14'th Jan 2026
Stock News Saks Global files Chapter 11: Saks Global (private) sought Chapter 11 protection, citing heavy debt from its 2024 Neiman Marcus deal and inventory st
Market Today: Boeing tops Airbus; Alphabet hits $4T
05:34pm, Tuesday, 13'th Jan 2026
Guru Stock PicksLarry Robbins has made the following transactions:Add in MYGN by 7.71%Stock News Trump floats 10% cap on card APRs: President Trump proposed a o
First Look: Fed Probe, Bank Cap Shock, Gold Soars, Deals
07:38am, Tuesday, 13'th Jan 2026
Stock News DOJ subpoenas Fed chair spark backlash: Federal prosecutors served grand jury subpoenas to Jerome Powell over testimony on Fed HQ renovations, prompt
BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to larg
Market Today: Banks, Big Tech, Biopharma and Energy Move on Policy and Deals
05:34pm, Monday, 12'th Jan 2026
Guru Stock PicksJerome Dodson has made the following transactions:Reduce in ORLY by 3%Sold out in BLDRAdd in NTRA by 2.49%New position in INSMTweedy Browne Inte
U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO
10:05pm, Friday, 09'th Jan 2026
U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO
Market Today: Meta taps nuclear; GM books $6B EV charge
05:35pm, Friday, 09'th Jan 2026
Stock News California billionaire tax splits tech leaders: Nvidia (NVDA) CEO Jensen Huang said he's âfineâ with a proposed one-time 5% California wealth tax
Aktis Oncology Jumps 27% After $318 Million Upsized IPO
01:24pm, Friday, 09'th Jan 2026
Aktis Oncology Inc. (AKTS) drew strong investor demand in its Nasdaq debut, with shares trading at $22.91 as of 12:19 p.m. Friday in New York after pricing its
Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets
12:58pm, Friday, 09'th Jan 2026
LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures (“Vida”), a next-generation life sciences venture firm, today congratulates Aktis Oncology (Nasdaq: AKTS), a clinical-stage biotechnology compa
Aktis Oncology prices upsized US IPO at $18 per share
09:20pm, Thursday, 08'th Jan 2026
Cancer drug developer Aktis Oncology said on Thursday it priced its upsized U.S. initial public offering at $18 per share, raising about $318 million.
